Table 1.
Descriptive epidemiologic data of patient cohort.
| Awake (n = 35) | Non-awake (GA) (n = 19) | |
|---|---|---|
| Age (years) | ||
| Mean | 55 [SEM ± 2.9] | 59 [SEM ± 2.8] |
| Range | 29–81 | 40–83 |
| Gender | ||
| Female | 21 | 7 |
| Male | 14 | 12 |
| Diagnosis | ||
| Glioblastoma (WHO IV) | 18 | 13 |
| Anaplastic oligodendroglioma (WHO III) | 2 | 0 |
| Anaplastic astrocytoma (WHO III) | 3 | 1 |
| Diffuse glioma (WHO II) | 2 | 0 |
| Astrocytoma IDH mutant (WHO II) | 5 | 0 |
| Cerebral metastases | 4 | 2 |
| Cerebral lymphoma | 0 | 3 |
| Ganglioglioma (WHO I) | 1 | |
| ECOG pre-op | ||
| Mean | 0.8 [SEM ± 0.1] | 1.0 [SEM ± 0.2] |
| ECOG post-op | ||
| Mean | 0.9 [SEM ± 0.2] | 1.2 [SEM ± 0.2] |
| Primary surgery | 25 | 12 |
| Recurrent surgery | 10 | 7 |
GA, general anesthesia; ECOG, Eastern Cooperative Oncology Group.